Publication: Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies
No Thumbnail Available
Date
2023-09-01
Authors
Tokalı F. S.
Şenol H.
Yetke H. İ.
Hacıosmanoğlu E.
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Description
Keywords
Eczacılık, Meslek Bilimleri, Farmasötik Kimya, Sağlık Bilimleri, Pharmacology and Therapeutics, Professional Sciences, Pharmaceutical Chemistry, Health Sciences, Klinik Tıp (MED), Yaşam Bilimleri (LIFE), Farmakoloji ve Toksikoloji, FARMAKOLOJİ VE ECZACILIK, Clinical Medicine (MED), Life Sciences (LIFE), PHARMACOLOGY & TOXICOLOGY, PHARMACOLOGY & PHARMACY, Farmakoloji, Farmakoloji, Toksikoloji ve Eczacılık (çeşitli), Genel Farmakoloji, Toksikoloji ve Eczacılık, Farmakoloji (tıbbi), İlaç Rehberleri, Yaşam Bilimleri, Pharmacy, Pharmacology, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), General Pharmacology, Toxicology and Pharmaceutics, Pharmacology (medical), Drug Guides, Life Sciences
Citation
Tokalı F. S., Şenol H., Yetke H. İ., Hacıosmanoğlu E., "Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies", ARCHIV DER PHARMAZIE, ss.1-16, 2023